Jefferies Financial Group Inc. Has $2.67 Million Stock Holdings in Kenvue Inc. (NYSE:KVUE)

Jefferies Financial Group Inc. decreased its holdings in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 67.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 125,000 shares of the company's stock after selling 263,181 shares during the quarter. Jefferies Financial Group Inc.'s holdings in Kenvue were worth $2,669,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of KVUE. Czech National Bank grew its holdings in shares of Kenvue by 6.6% during the fourth quarter. Czech National Bank now owns 415,700 shares of the company's stock valued at $8,875,000 after buying an additional 25,561 shares in the last quarter. Wedmont Private Capital grew its holdings in shares of Kenvue by 11.5% during the fourth quarter. Wedmont Private Capital now owns 13,044 shares of the company's stock valued at $272,000 after buying an additional 1,344 shares in the last quarter. FNY Investment Advisers LLC grew its holdings in shares of Kenvue by 167.3% during the fourth quarter. FNY Investment Advisers LLC now owns 21,208 shares of the company's stock valued at $452,000 after buying an additional 13,274 shares in the last quarter. Exeter Financial LLC grew its holdings in shares of Kenvue by 6.7% during the fourth quarter. Exeter Financial LLC now owns 12,721 shares of the company's stock valued at $272,000 after buying an additional 800 shares in the last quarter. Finally, Pines Wealth Management LLC purchased a new position in shares of Kenvue during the fourth quarter valued at $237,000. Hedge funds and other institutional investors own 97.64% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on KVUE shares. Redburn Atlantic started coverage on Kenvue in a report on Thursday, April 10th. They set a "neutral" rating and a $23.50 price target on the stock. UBS Group boosted their target price on Kenvue from $24.00 to $25.00 and gave the company a "neutral" rating in a research note on Friday, May 9th. Canaccord Genuity Group boosted their target price on Kenvue from $24.00 to $29.00 and gave the company a "buy" rating in a research note on Wednesday, March 5th. Evercore ISI started coverage on Kenvue in a research note on Monday, March 24th. They issued an "in-line" rating and a $25.00 target price on the stock. Finally, Royal Bank of Canada restated a "sector perform" rating and issued a $24.00 target price on shares of Kenvue in a research note on Monday, February 3rd. Seven research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, Kenvue presently has an average rating of "Hold" and a consensus price target of $25.33.

Kenvue Stock Up 1.1%

Shares of NYSE:KVUE traded up $0.27 on Friday, reaching $24.15. The company had a trading volume of 19,921,749 shares, compared to its average volume of 16,552,309. Kenvue Inc. has a twelve month low of $17.67 and a twelve month high of $25.17. The stock has a 50-day moving average price of $23.16 and a 200 day moving average price of $22.59. The stock has a market capitalization of $46.34 billion, a P/E ratio of 45.57, a P/E/G ratio of 2.62 and a beta of 1.02. The company has a quick ratio of 0.69, a current ratio of 1.00 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.24 earnings per share for the quarter, topping analysts' consensus estimates of $0.23 by $0.01. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. The company had revenue of $3.74 billion during the quarter, compared to analysts' expectations of $3.69 billion. During the same quarter in the previous year, the firm earned $0.28 earnings per share. The business's quarterly revenue was down 3.9% compared to the same quarter last year. On average, equities analysts expect that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 28th. Shareholders of record on Wednesday, May 14th will be given a $0.205 dividend. The ex-dividend date of this dividend is Wednesday, May 14th. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.40%. Kenvue's dividend payout ratio is currently 149.09%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.